key: cord-0934989-8vp4kfim authors: Mapanguy, Claujens Chastel Mfoutou; Batchi-Bouyou, Armel Landry; Djontu, Jean Claude; Pallerla, Srinivas Reddy; Ngoma, Chamy Helga; Linh, Le Thi Kieu; Rachakonda, Sivaramakrishna; Casadei, Nicolas; Angelov, Angel; Sonnabend, Michael; Vouvoungui, Jeannhey Christevy; Ampa, Raoul; Nguimbi, Etienne; Peter, Silke; Kremsner, Peter G.; Montaldo, Chiara; Velavan, Thirumalaisamy P.; Ntoumi, Francine title: SARS-CoV-2 B.1.214.1, B.1.214.2 and B.1.620 are predominant lineages between December 2020 and July 2021 in the Republic of Congo date: 2022-03-10 journal: IJID Regions DOI: 10.1016/j.ijregi.2022.03.009 sha: 6d9f3f1e99bd58e6db13fffc987ea179f24b99db doc_id: 934989 cord_uid: 8vp4kfim Background The SARS-CoV-2 variants have been emerging and is shown to increase transmissibility, pathogenicity, and decreased vaccine efficacies. The objective of this study was to determine the distribution, prevalence, and dynamics of SARS-CoV-2 variants circulating in Brazzaville, the Republic of Congo (ROC). Methods Between December 2020 and July 2021, a total of n=600 oropharyngeal specimens collected in the community were tested for COVID-19. Of the samples tested, 317 (53%) were SARS-CoV-2 positive. All samples that had a threshold of Ct <30 (n=182) was sequenced by next-generation sequencing (NGS), and all complete sequenced genomes were submitted to GISAID, and lineages were assigned using pangolin nomenclature and a phylogenetic tree was reconstructed. In addition, the global prevalence of the predominant lineages was analysed using data from GISAID and Outbreak databases. Results A total of 15 lineages circulated with B.1.214.2 (26%), B.1.214.1 (19%) and B.1.620 (18%) being the predominant. The variants of concern (VOC) alpha (B.1.1.7) (6%) and for the first time in June delta (B.1.617.2) (4%) were observed. In addition, the B.1.214.1 lineage first reported from ROC was observed to be spreading locally and regionally. Phylogenetic analysis suggests that the B.1.620 variant (VUM) under observation may have originated from either Cameroon or the Central African Republic. SARS-CoV-2 lineages were heterogeneous, with the densely populated districts of Poto-Poto and Moungali likely the epicenter of spread. Conclusion Longitudinal monitoring and molecular surveillance across time and space are critical to understanding viral phylodynamics, which could have important implications for transmissibility and impact infection prevention and control measures. The ongoing global Coronavirus disease 2019 (COVID-19) pandemic has caused significant mortality and morbidity (Velavan and Meyer 2020) , requiring unprecedented efforts to develop vaccines for COVID-19. The SARS-CoV-2 virus is constantly mutating, leading to new variants. The variants can alter viral properties, leading to increased transmissibility and virulence, compromising treatments, diagnostics failure, and vaccine efficacy. Currently, emergence of SARS-CoV-2 variants with extensive mutations in the spike (S) protein has raised concerns about increased transmission, vaccines, therapeutics, and diagnostics (Wu et al. 2021; Wang, Nair, et al. 2021 ). In the early stages of the pandemic, the effects of selective advantage of SARS-CoV-2 S mutation D614G on transmissibility was documented (Korber et al. 2020; Volz et al. 2021 ). Further it is well known that the S protein mediates SARS-CoV-2 entry into host cells and is crucial for protective antibody responses, also being the antigen component of all the COVID-19 vaccines (Kemp et al. 2021) . Multiple variants of SARS-CoV-2 have been documented worldwide during this pandemic. Particularly, "variants of concern" (VOC), alpha (B.1.1.7), beta (B.1.351), and gamma (B.1.1.28/P1), delta (B.1.617.2) are associated with increased transmission, increased mortality, decreased vaccine efficacies (Bal et al. 2021; Gaymard et al. 2021; Challen et al. 2021; Davies et al. 2021; Twohig et al. 2021) . It is apparent that the variant alpha, which contains a deletion at position 69-70 of the S protein, leads to an "S gene target failure", i.e. a loss of amplification (Bal et al. 2021; Gaymard et al. 2021) , whereas the results for Beta are more concerning, as this variant is significantly more resistant to neutralization by convalescent plasma and vaccinees' sera, mainly due to the E484K mutation (Wang, Nair, et al. 2021 ). The P.1 and delta is reported increase transmissibility, virulence, and overall reduction in effective neutralization (Voloch et al. 2020; Felipe et al. 2021; Garcia-Beltran et al. 2021; Voloch et al. 2021) . The delta variant with spike mutations P681R, E484Q, and L452R, is alarming because the E484Q and L452R mutations are independently resistant to neutralizing antibodies (Focosi and Maggi 2021) . Currently, delta was the most predominant variant circulating around the world (www.gisaid.com) and is known to cause breakthrough infections (Riemersma et al. 2021) . Similarly, there are other emerging variants of SARS-CoV-2 that are also gaining attention as they are known as "variant of interest" (VOI) -lambda (C.37) and Mu (B.1.621) (WHO 2021c), which also appear to be associated with transmissibility and warrant further functional studies. The variants suspected of posing a future risk are defined as "variants under monitoring" (VUM) (Khare et al., 202 ) . Phylogenomic analysis of these genomes revealed that most transmission occurred within African countries and between Africa and Europe (Wilkinson et al. 2021) . Recent reports suggest that the B.1.620 lineage, which is VUM and has several mutations and deletions in the S protein that resemble VOCs, originated in west central Africa (Dudas et al. 2021 ). Because of low vaccination coverage and the high prevalence of immune-compromised diseases such as HIV, tuberculosis, and other infectious diseases, the virus may re-emerge and continue to spread. Therefore, genomic surveillance of SARS-CoV-2 variants is essential to understanding viral dynamics, particularly transmissibility, virulence, and pathogenesis. In Republic of Congo first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections reported on 14 th March 2020 (Ntoumi, 2020; Ntoumi and Velavan 2020) , and as of Oct. 2021 a total of 15,962 cases reported with 231 deaths (WHO). The ROC was the first country in Central Africa to report a very high exposure of its population to SARS-CoV-2 through a seroprevalence study (Batchi-Bouyou et al. 2021) . Since then, the high exposure of the Congolese population, the emergence and rapid spread of VOCs across the globe have emphasized the need for genomics surveillance, that can help guide interventions to mitigate the COVID-19 pandemic in the country by informing prevention strategies. Since Brazzaville, the capital of RoC concentrates more than 50% of reported cases (SITREP 153, June 2021) the objective of this study was to determine the distribution, prevalence, and dynamics of SARS-CoV-2 variants circulating in Brazzaville, ROC, between December 2020 and July 2021. Oropharyngeal swabs from symptomatic and asymptomatic individuals (n=600) were obtained and screened for COVID-19 between December 2020 and July 2021 in Brazzaville, Republic of Congo (ROC). RNA was extracted from swabs using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) and subjected to RealStar® SARS-CoV-2 real-time PCR targeting the S gene of SARS-CoV-2 (Altona Diagnostics, Hamburg, Germany) by using a LightCycler® 480 Instrument II (Roche diagnostics, Mannheim, Germany). Out of 317 individuals tested positive for COVID-19, 182 were Next-Generation Sequencing (NGS) with a Ct <30. For Illumina sequencing libraries were prepared as described in COVID-19 ARTIC v3 Illumina protocol V.5 (DNA Pipelines R&D 2020), using the NEBNext Ultra II DNA Library Prep Kit (New England Biolabs) and for Oxford Nanopore sequencing Technology (ONT), libraries were prepared as described in Freed et al., (RAPID barcoding, 1200bp amplicon) (Freed et al. 2020 ). The libraries were quantified (Qubit DNA BR, Thermo Scientific), and sequenced on Illumina MiSeq V2 (500 cycles) and ONT. The FastQ files obtained from sequencing were analysed using the nf-core/viralrecon (Ewels et al. 2020 ) and artic network field bioinformatics pipeline for ONT data. The 171 genomes were deposited in GISAID (Khare et al., 2021) and the lineages of these genomes were annotated by Pangolin online tool (O'Toole et al. 2021 ). To investigate the global prevalence of B.1.214.1, B.1.214.2, and B.1.620 predominated lineages in this study, we obtained data of these lineages from GISAID (www.gisaid.com) and Outbreak.info (Julia L. Mullen 2020). SARS-CoV-2 genomes between December 2020 and July 2021 from various African and European countries and Wuhan reference sequence were retrieved from GISAID and as reported that most of the transmissions happened between within Africa and between Africa and Europe (Wilkinson et al. 2021 were included because many of the genomes were genetically identical. The sequences that have the quality according to selected criteria (complete genome, high quality control and coverage of the sequence) were aligned using a multiple sequence alignment (MAFTT) (Katoh et al. 2002 ). Subsequently, phylogenetic tree was reconstructed with the maximum likelihood method using the general time-reversible (GTR) model with rate heterogeneity (GTR+G) in the IQ-TREE server (Trifinopoulos et al. 2016) . A 1000 bootstrap iterations by ultrafast bootstrap was computed (Hoang et al. 2018 ) and were classified into Pangolin lineages (Rambaut et al. 2020 ). The final dataset was displayed with the Interactive Tree of Life (iTOL) v6 (Letunic and Bork 2019) . The characteristics of the SARS-CoV-2 infected patients from whom the 171 genomes were sequenced are summarized in Table 1 . The median age of the patients was 34 years (IQR: 25 to 47) and 67% (115/171) were males. The distribution of the genomes deposited between December 2020 to July 2021 are summarized as following 18 (31/171), 12% (20/171), 33% (57/171), 6% (10/171), 4% (7/171), 2% (3/171), 17% (29/171) and 8% (14/171) respectively (Table 1) . The 171 genomes were assigned to different pangolin lineages (Table 2) Table 3 ). The list of top 10 countries that have deposited these three lineages were shown in Table 3 (Table 3 ). The prevalence of these lineages in ROC, Belgium and South Korea was 12%, 1% and 3%, respectively based on the total number of sequences deposited by these countries. The number of deposited genomes and their prevalence for these three lineages (Table 3) This indicate that there were two separate introductions into the country that were locally transmitted. Next, the ROC genomes of the B.1.214.1 lineage formed a single cluster with genomes from Angola and France, from where few cases with this lineage have been reported. In addition, the genomes of the B.1.620 lineage from the ROC formed a monophyletic cluster with genomes from Cameroon, CAR, France, Belgium, Germany, and England, suggesting single introduction and local transmission. (Figure 4 ). The genomes of B.1.1.7 lineage from ROC formed two distinct clusters in a monophyletic group with the genomes from Europe and Africa ( Figure 4) . Next, the genomes of the Delta lineage clustered with the genomes from France, Germany, Belgium, Angola, and the CAR suggest that the variants may have been introduced from European and/or West African countries bordering the ROC. The findings of the present study were the identification of 15 lineages found in Brazzaville,ROC and 11 lineages were reported for the first time. The study reports that the alpha and delta VOCs and B.1.214.2 and B.1.620 VUMs for the first time in ROC and found that B.1.214.2, B.1.214.1, and B.1.620 were the predominant lineages in circulation. The lineages B.1.620 and B.1.617.2 first appeared in May and June, respectively, and were still circulating at the end of the study. The genomes in this study formed tight clusters with genomes from Europe and Africa and strengthening earlier findings that most of the introductions of the variants happened between within Africa and between Africa and Europe. As SARS-CoV-2 transmission lineages are growing and spreading, they will become more difficult to eliminate, underscoring the importance of timely intervention to reduce transmission. This will add to the public health burden in resource-poor areas in ROC and Africa in general. An important aspect of early epidemiological and genomic surveillance is essential in understanding the lineages introduced into a region. Europe and other countries (Dudas et al. 2021) . This lineage has been introduced into several countries and transmitted locally in Lithuania, France, Spain, Italy, Germany, and ROC. In Africa, most sequences were deposited, and highest prevalence is reported from ROC (this study) and the neighbouring country CAR. The phylogenetic tree and data suggest that transmission of this lineage may have occurred through Cameroon and/or the CAR, as both countries share a border with the ROC. This clearly indicates that transmission across the borders could have occurred during economic activities between the countries. Most of the sequences in this lineage were introduced from non-African countries such as South Korea, Lithuania, France, and Germany (Khare et al., 2021) . However, relative to the total number of the sequences deposited in GISAID, the overall prevalence is low in these countries. For several reasons this lineage may be of concern (Dudas et al. 2021): 1) it has a large number of VOC-like mutations and deletions; 2) it is reported to be 2.4-fold more frequent in vaccine breakthrough cases, possibly due to escaping antibody-mediated immunity; 3) mutations of B.1.620 in the NTD (N-terminal domain) may result in partial loss of neutralization of convalescent serum and NTDtargeted monoclonal antibodies (Wang, Casner, et al. 2021) . It is suggested that this lineage may have arisen through escape from antibody-mediated immunity (Liu et al. 2021) . Mutation studies have shown that substitutions increase the affinity of the RBD for the ACE2 receptor (Starr et al. 2020 ). Overall, close monitoring of this variant is needed in ROC and in other African countries, as it is potentially of concern. It is reported that the alpha and delta VOCs are the predominant variants circulating in almost all countries of the world, including in ROC (Khare et al., 2021) . In the present study, we show low frequencies of these variants and probably due to their recent introduction into the ROC. The individuals who exhibited the VOCs in the present study had no recent travel history. Nevertheless, both variants showed tight clusters with genomes of the lineage from European and African countries, which makes difficult to predict the introductions and transmission patterns. Phylogenetic analysis of the sequences in this study shows high similarities between the sequences, suggesting a single introduction and local spread within a shorter period. The distribution of variants in Brazzaville was heterogeneous, with the Poto-Poto and Moungali districts harbouring the most variants and representing an epicenter of viral genetic diversity. The highest diversity of SARS-CoV-2 in the Poto-Poto district may be due to the fact that the population of this district is cosmopolitan and has high economic activity. Indeed, the district has a large market that attracts not only people from all parts of the country but also foreign traders. However, the escalation of the disease in the neighbouring Democratic Republic of Congo (DRC) explains the rapid transmission of the variants in the Republic of Congo due to the proximity of the cities (Brazzaville and Kinshasa are the closest capitals in the world). Since the Poto-Poto district is located on the border, this explains the fact that it is the epicentre. The data illustrate the high dynamics of SARS-CoV-2 variants in Congo. Limitations of our study include that the lineages and predominance may be highly biased by differences in Ct values (only the samples with low Ct values were included for sequencing) and also several districts in ROC were not covered, which may not reveal the true perspective of the variants circulating in the country. Also, our efforts to reconstruct the dynamics of SARS-CoV-2 in ROC and Africa are certainly biased by the uneven sampling. Our previous study from the ROC reported limited SARS-CoV-2 diversity from sequences between April and July 2020. In that study, all SARS-CoV-2 genomes were reported to carry the S mutation D614G and only lineage B.1 was observed, with two separate introductions of SARS-CoV-2 virus likely from DRC (Ntoumi et al. 2021 ). Together, the results from the present study indicate that many SARS-COV-2 variants are circulating in Brazzaville, ROC, and the detection of alpha and delta variants for the first time in the country is the raised alarm to the health authorities. Thus, the spatiotemporal genomic surveillance of SARS-CoV-2 variants will be useful in monitoring viral evolution and emerging variants, transmissibility, transmission dynamics, assessing vaccine efficacy, and evaluating infection prevention and control measures in the ROC. Informed written consent was obtained from all participants. The study was approved by the ministry of scientific research and technological innovation, ROC (Approval Nr. 049/MRSIT-CAB) and by institutional ethics committee of the Congolese foundation for medical research (Approval Nr. 027/CIE/FCRM/2020). All authors agreed with the results and conclusions. All authors consented this version of the manuscript to be published. Availability of data and materials. All related data supporting the results reported in the article is available within the manuscript. Declaration of Competing Interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. December 2020 31 (18) January 2021 20 (12) February 2021 57 (33) March 2021 10 (6) April 2021 07 (4) May 2021 03 (2) June 2021 29 (17) OVID-Diagnosis HCL Study Group. 2021. 'Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70 High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7 COVID-19 ARTIC v3 Illumina library construction and sequencing protocol V Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions The nf-core framework for community-curated bioinformatics pipelines Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France Emergence of a recurrent insertion in the N-terminal domain of the SARS-CoV-2 spike glycoprotein UFBoot2: Improving the Ultrafast Bootstrap Approximation Karthik Gangavarapu, Laura D. Hughes, and the Center for Viral Systems Biology 2020 MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform Citiid-Nihr BioResource COVID-19 Collaboration SARS-CoV-2 evolution during treatment of chronic infection GISAID Core Curation Team, and Maurer-Stroh S.. 2021. 'GISAID's Role in Pandemic Response Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus Interactive Tree Of Life (iTOL) v4: recent updates and new developments Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization What if tropical diseases had as much attention as COVID? Nature COVID-19 in Africa: between hope and reality Genomic surveillance of SARS-CoV-2 in the Republic of Congo Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Shedding of Infectious SARS-CoV-2 Despite Vaccination Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding', Cell W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study Mild versus severe COVID-19: Laboratory markers Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7', Nature WHO. 2021a. 'COVID-19 (WHO African region) (EPR/HIR) (acessed on 06 Tracking SARS-CoV-2 variants A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine -Preliminary Report SARS-CoV-2 lineages and the prevalence of B.1.214.1, B.1.214.2 and B France: 8 (< 0.1) Switzerland: 267 (< 0.1) Lithuania We are grateful to all the participants who accepted to contribute in this study. We acknowledge Marie Gauder from the Quantitative Biology Center (QBiC) Tübingen for her support in data management. We also acknowledge the authors, originating and submitting laboratories of the genetic sequences and metadata made available through GISAID.